Analyst firms · Piper Sandler · SNPS

Piper Sandler SNPS price target and rating history

Synopsys Inc. (SNPS) · Technology

Piper Sandler rates Synopsys Inc. (SNPS) Overweight with a $550 price target, as of its latest action on Jun 23, 2026. It has published 3 rating actions on SNPS since April 2024, including 1 upgrade and 1 downgrade. Across 11 firms with a SNPS price target in the last 12 months, the median target is $560. Piper Sandler's $550 is 2% below that.

Current rating
Overweight
Price target
$550
Median target, all firms
$560
Actions on SNPS
3

Piper Sandler price target on SNPS

$665$593$52020252026
Piper Sandler price target on SNPS, each point a stated target, April 2024 to June 2026.

Every Piper Sandler rating on SNPS

How other firms rate SNPS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysOverweight$640Nov 19, 2026
HSBCBuy$700Sep 25, 2026
BNP Paribas ExaneNeutral$420Sep 24, 2026
Wells FargoOverweight$475Sep 10, 2026
Morgan StanleyOverweight$500Sep 8, 2026
Robert W. BairdOutperform$560Aug 27, 2026
The Benchmark CompanyBuy$570Jul 16, 2026
Piper SandlerOverweight$550Jun 23, 2026
BofA SecuritiesBuy$560Dec 11, 2025
RosenblattBuy$560Dec 9, 2025
CitigroupBuy$580Nov 24, 2025

Questions about Piper Sandler and SNPS

What is Piper Sandler's price target for SNPS?
Piper Sandler's latest stated price target for Synopsys Inc. (SNPS) is $550, from its action on Jun 23, 2026.
What is Piper Sandler's rating on SNPS?
Piper Sandler rates SNPS Overweight, a bullish rating, as of Jun 23, 2026.
When did Piper Sandler last change its view on SNPS?
On Jun 23, 2026, Piper Sandler upgrades to Overweight from Neutral, price target $550.
How does Piper Sandler's SNPS target compare with other analysts?
Across 11 firms with a SNPS price target in the last 12 months, the median target is $560. Piper Sandler's $550 is 2% below that.

More SNPS rating histories

All Piper Sandler ratingsSNPS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.